TABLE 2.

Information statistics results of 15 samples^a

Sample	Seq._num.	Base_num.	Mean_length	Min._length	Max._length
a1	64170	26358289	410.7571918	245	431
a2	51619	21152424	409.7798098	229	448
a3	43326	17693479	408.3801643	239	431
a4	48687	19924760	409.2418921	236	483
a5	65732	26902937	409.2821913	219	431
b1	49531	21210479	428.2263431	403	431
b2	53365	22827074	427.7536588	239	431
b3	47583	20377586	428.2534939	245	432
b4	56164	24051066	428.2292216	402	430
b5	58257	24936564	428.0440805	239	432
c1	50956	21267011	417.3602912	243	432
c2	46040	19224392	417.5584709	310	434
c3	57195	23879299	417.5067576	242	466
c4	53583	22372220	417.5245880	234	458
c5	49079	20455086	416.7787852	262	432

^aColumns 1–6 are sample-related information, followed by sample number sequence number, base number, mean length, shortest sequence length, and longest sequence length. Control groups (a1 to a5) were injected with phosphate-buffered saline; infected groups (b1 to b5) were injected with S. agalactiae; and treatment groups (c1-c5) were treated with LLK48 after S.agalactiae injection.